Amalgamated Bank’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-112
Closed -$10K 3021
2024
Q1
$10K Sell
112
-91
-45% -$8.73K ﹤0.01% 2425
2023
Q4
$21K Sell
203
-9
-4% -$907 ﹤0.01% 2618
2023
Q3
$23K Sell
212
-11
-5% -$1.22K ﹤0.01% 2573
2023
Q2
$24K Buy
+223
New +$25.1K ﹤0.01% 2638

Other funds holding BNTX

Amalgamated Bank's BNTX Position: Q2 2024 in Review

Amalgamated Bank sold out of BioNTech (BNTX) in Q2 2024, closing a stake of 112 shares — an estimated $10K sold.

Amalgamated Bank first reported a position in BNTX in Q2 2023 and held it in 4 quarters. The position peaked at $24K in Q2 2023. 286 funds tracked by Wall St. Rank hold BNTX as of Q2 2024.

  • Amalgamated Bank reported no remaining BioNTech position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 112 BioNTech shares in Q2 2024, an estimated $10K.
  • Amalgamated Bank first reported a position in BioNTech in Q2 2023 and held it in 4 quarters.
  • Amalgamated Bank's BioNTech position peaked at $24K in Q2 2023.
  • 286 funds tracked by Wall St. Rank held BioNTech as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.